Wolverine Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Wolverine Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-51,101	Closed	-$323K	–	2321
2022 Q4	$323K	Buy	51,101 +4,137	+9%	+$22.9K	﹤0.01%	1038
2022 Q3	$240K	Buy	46,964 +44,764	+2,035%	+$281K	﹤0.01%	1199
2022 Q2	$13K	Buy	+2,200	New	+$7.41K	﹤0.01%	1932

Wolverine Asset Management's FSTX Position: Q1 2023 in Review

Wolverine Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 51,101 shares — an estimated $323K sold.

Wolverine Asset Management first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $323K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Wolverine Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 51,101 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $323K.
Wolverine Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Wolverine Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $323K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.